Abstract
Formulation and Stability of Solutions
Author(s): Akers Michael J
Issue: Jan/Feb 2016 - Volume 20, Number 1
Page(s): 41-45
Download in electronic PDF format for $75
Abstract
Ready-to-use solutions are the most preferable and most common dosage forms for injectable and topical ophthalmic products. Drugs formulated as solution almost always have chemical and physical stability challenges as well as solubility limitations and the need to prevent inadvertent microbial contamination issues. This article, which takes us through a discussion of optimizing the physical stability of solutions, represents the first of a series of articles discussing how these challenges and issues are addressed.
Related Keywords
- ready-to-use solutions
- compounded sterile preparations
- sterile dosage forms
- sterile drug solutions
- biopharmaceuticals
- instability
- aggregation
- precipitation
- hydrolytic stability
- drug degradation mechanisms
- stabilizing additives
- storage temperature
- hydrolysis
- potency
- therapeutic proteins
- large molecules
- optimal solution pH
- solubility
- quality control
- amino acid sequence
- buffers
- dissociation constants
- oxidation
- oxidative stability
- antioxidants
- chelating agents
- inert gases
- physical stability
- denaturation
Related Categories
- PACKAGING
- PARENTERALS
- STABILITIES, COMPATIBILITIES
- STERILE PREPARATIONS
- DOSAGE FORMS/DRUG CARRIERS
- STORAGE
Related Articles from IJPC
Issue/Page View/Buy |
Title/Author (Click for Abstract / Details / Purchase) |
---|---|
Jan/Feb 2016
Pg. 41-45
|
Author(s):
Akers Michael J
|
Nov/Dec 2017
Pg. 481-486
|
Author(s):
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 47-56
|
Author(s):
Akers Michael J
|
Jan/Feb 2004
Pg. 46-48
|
Author(s):
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 399-404
|
Author(s):
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 301-308
|
Author(s):
Akers Michael J
|
Mar/Apr 2016
Pg. 137-141
|
Author(s):
Akers Michael J
|
May/Jun 2019
Pg. 221-228
|
Author(s):
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 41-49
|
Author(s):
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 31-38
|
Author(s):
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 399-402
|
Author(s):
Allen Loyd V Jr
|
Sep/Oct 2018
Pg. 387-398
|
Author(s):
Ashe Krystina, Baskett Dustin
|
Mar/Apr 2017
Pg. 133-142
|
Author(s):
Akers Michael J
|
May/Jun 2022
Pg. 219-228
|
Author(s):
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 479-484
|
Author(s):
Akers Michael J
|
Mar/Apr 2004
Pg. 89-94
|
Author(s):
Rahe Hank
|
Sep/Oct 2023
Pg. 397-409
|
Author(s):
Allen Loyd V Jr
|
May/Jun 2017
Pg. 223-228
|
Author(s):
Akers Michael J
|
Nov/Dec 2023
Pg. 474-481
|
Author(s):
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 307-311
|
Author(s):
McElhiney Linda F
|